Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Aurora Diagnostics Cancels Plans for an IPO

By LabMedica International staff writers
Posted on 20 Jun 2012
Aurora Diagnostics (Palm Beach Gardens, FL, USA), a specialized diagnostics company focusing on the anatomic pathology market, canceled its long-delayed plans for an initial public offering (IPO) on June 6, 2012. More...
The company asked the US Securities and Exchange Commission (SEC) to withdraw its registration statement because it had decided not to pursue an initial public offering (IPO) or stock market launch.

In April 2010, Aurora Diagnostics was seeking to raise up to USD 150 million. Although it never set a date or price for that offering, the company updated its financial results every quarter to keep its eligibility for the offering current. It even held several conference calls for prospective investors. Aurora Diagnostics raised USD 200 million in December 2010 through a private bond placement.

Aurora Diagnostics lost USD 32.9 million in 2011 on revenue of USD 277.5 million, compared with a USD 3.7 million loss on revenue of USD 212.8 million the year before. It followed that up in the first quarter with a USD 2.1 million loss on revenue of USD 72.1 million, compared with a USD 2 million loss on revenue of USD 62.6 million in the same period a year ago.

Related Links:

Aurora Diagnostics



Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A schematic illustrating the coagulation cascade in vitro (Photo courtesy of Harris, N., 2024)

ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners

Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more

Microbiology

view channel
Image: EBP and EBP plus have received FDA 510(k) clearance and CE-IVDR Certification for use on the BD COR system (Photo courtesy of BD)

High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample

Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.